Discontinued — last reported Q4 '25
Intangibles (Net)
AbbVie Intangibles (Net) increased by 896.8% to $52.64B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 12.4%, from $60.07B to $52.64B. Over 5 years (FY 2020 to FY 2025), Intangibles (Net) shows a downward trend with a -8.7% CAGR.
Analysis
How to read this metric
An increase often follows strategic acquisitions or significant R&D capitalization, while a decrease may indicate amortization or impairment charges.
Detailed definition
This represents the net book value of non-physical assets, such as patents, trademarks, software, and customer relations...
Peer comparison
Highly relevant for healthcare and technology firms; peers often disclose the composition of these assets in financial footnotes.
intangible_assets_netHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.55B | $1.45B | $75.95B | $670.00M | $670.00M | $670.00M | $67.44B | $289.00M | $293.00M | $285.00M | $55.61B | $1.58B | $1.58B | $9.70B | $60.07B | $5.29B | $5.29B | $5.28B | $52.64B |
| QoQ Change | — | -6.5% | >999% | -99.1% | +0.0% | +0.0% | >999% | -99.6% | +1.4% | -2.7% | >999% | -97.2% | +0.0% | +513.6% | +519.6% | -91.2% | -0.1% | -0.1% | +896.8% |
| YoY Change | — | — | — | — | -56.8% | -53.8% | -11.2% | -56.9% | -56.3% | -57.5% | -17.5% | +446.7% | +439.2% | >999% | +8.0% | +234.9% | +234.6% | -45.5% | -12.4% |
Product Breakdown — Emraclidine
| Segment | Q4 '24 |
|---|---|
| Emraclidine | $6.90B |
| Total | $60.07B |
Product Breakdown — Imbruvica
| Segment | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 |
|---|---|---|---|---|
| Coolsculpting | — | — | — | $1.30B |
| Liletta | — | — | — | $561.00M |
| Imbruvica | $4.80B | $4.30B | $1.90B | — |
| Total | $289.00M | $293.00M | $285.00M | $55.61B |
Imbruvica was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.
Intangibles (Net) at Other Companies
Frequently Asked Questions
- What is AbbVie's intangibles (net)?
- AbbVie (ABBV) reported intangibles (net) of $52.64B in Q4 2025.
- How has AbbVie's intangibles (net) changed year-over-year?
- AbbVie's intangibles (net) decreased by 12.4% year-over-year, from $60.07B to $52.64B.
- What is the long-term trend for AbbVie's intangibles (net)?
- Over 5 years (2020 to 2025), AbbVie's intangibles (net) has grown at a -8.7% compound annual growth rate (CAGR), from $82.88B to $52.64B.
- What does intangibles (net) mean?
- The value of non-physical assets like patents and brands after accounting for amortization.